CMIC Holdings Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CMIC Holdings Co Ltd with three other
companies in this sector in Japan:
Zeria Pharmaceutical Co Ltd
sales of 64.85 billion Japanese Yen [US$584.30 million]
of which 53%
was Pharmaceuticals Business),
Iwaki & Co., Ltd.
(57.39 billion Japanese Yen [US$517.06 million]
Aska Pharmaceutical Company Limited
(48.53 billion Japanese Yen [US$437.23 million]
of which 91%
was Pharmaceutical Products Business).
CMIC Holdings Co Ltd reported sales of ¥65.28 billion (US$588.19 million)
September of 2017.
increase of 5.2%
versus 2016, when the company's sales were ¥62.04 billion.
Sales at CMIC Holdings Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 30%).
Sales of Cro Business saw an increase
that was more than double the company's growth rate: sales were up
16.5% in 2017, from
¥29.20 billion to ¥34.02 billion.
CMIC Holdings Co Ltd also saw significant increases in sales in
Healthcare Business (up 11.6% to ¥7.63 billion)
Not all segments of CMIC Holdings Co Ltd experienced an increase in sales in 2017:
sales of Cso Business fell 25.9% to ¥6.89 billion.
CMIC Holdings Co Ltd also experienced decreases in sales in
Ipm Business (down 8.2% to ¥2.38 billion)